Endothelial Dysfunction Plays a Key Role in Increasing Cardiovascular Risk in Type 2 Diabetes: The Hoorn Study

In the pathogenesis of cardiovascular events, interaction between risk factors has seldom been identified. However, endothelial dysfunction on the one hand and type 2 diabetes mellitus, impaired glucose metabolism (IGM), and insulin resistance on the other may act synergistically (ie, interact) in the development of cardiovascular disease. We therefore investigated the interaction between endothelial dysfunction and type 2 diabetes mellitus, IGM, and insulin resistance with regard to risk of cardiovascular events. In a prospective population-based cohort (n=445; 69 years; 55% women; 23% type 2 diabetes mellitus, 28% IGM [by design]), endothelial dysfunction (brachial artery flow-mediated dilatation), glucose tolerance (oral glucose tolerance test), and insulin sensitivity (homeostasis model assessment for insulin resistance [HOMA2-IR]) were determined. After a median follow-up of 7.6 years, 106 participants had had a cardiovascular event. After adjustments, 1 SD less flow-mediated dilatation was associated with cardiovascular events in type 2 diabetes mellitus (hazard ratio 1.69 [95% confidence interval, 1.14–2.52]) and IGM (1.50 [0.95–2.37]) and among those in the highest HOMA2-IR tertile (1.92 [1.42–2.60]), but not in normal glucose metabolism (0.85 [0.63–1.16]) or among those in the lower 2 HOMA2-IR tertiles combined (0.85 [0.65–1.12]). Interaction between flow-mediated dilatation and type 2 diabetes mellitus, IGM, or insulin resistance was present on an additive (relative excess risk caused by interaction >0) and on a multiplicative scale (P interaction <0.05). Endothelial dysfunction and type 2 diabetes mellitus, IGM, or insulin resistance synergistically increase cardiovascular event risk. This identifies endothelial dysfunction as a key therapeutic target in these individuals.

[1]  C. Stehouwer,et al.  Microvascular Dysfunction Is Associated With a Higher Incidence of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[2]  J. Gallacher,et al.  Lipid-related markers and cardiovascular disease prediction. , 2012, JAMA.

[3]  G. Nijpels,et al.  Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: the Hoorn Study , 2012, Journal of hypertension.

[4]  K. Dharmashankar,et al.  Acute Exposure to Low Glucose Rapidly Induces Endothelial Dysfunction and Mitochondrial Oxidative Stress: Role for AMP Kinase , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[5]  E. Ford,et al.  Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. , 2010, Journal of the American College of Cardiology.

[6]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[7]  M. Zou,et al.  Molecular insights and therapeutic targets for diabetic endothelial dysfunction. , 2009, Circulation.

[8]  M. Tal.  Type 2 diabetes: Microvascular ischemia of pancreatic islets? , 2009, Medical hypotheses.

[9]  R. D'Agostino,et al.  Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease: The Framingham Offspring Study , 2008, Circulation.

[10]  R. Testa,et al.  Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients , 2008, Diabetes.

[11]  D. Grobbee,et al.  Estimating interaction on an additive scale between continuous determinants in a logistic regression model. , 2007, International journal of epidemiology.

[12]  J. Danesh,et al.  Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies. , 2007, European heart journal.

[13]  L. Bouter,et al.  Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Hoorn Study , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[14]  M. Quon,et al.  Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms , 2006, Circulation.

[15]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[16]  L. Bouter,et al.  Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study. , 2004, Atherosclerosis.

[17]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[18]  S. Lewington.  Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[19]  E. Barrett,et al.  Blood flow and muscle metabolism: a focus on insulin action. , 2003, American journal of physiology. Endocrinology and metabolism.

[20]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[21]  L. Bouter,et al.  Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. , 2002, Diabetes care.

[22]  J. Shaw,et al.  Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[23]  E. Benjamin,et al.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.

[24]  R. Reneman,et al.  An integrated system for the non-invasive assessment of vessel wall and hemodynamic properties of large arteries by means of ultrasound. , 1999, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[25]  R S Reneman,et al.  Non-invasive measurement of mechanical properties of arteries in health and disease , 1999, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[26]  A. Donker,et al.  Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. , 1996, Arteriosclerosis, thrombosis, and vascular biology.